These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 26083617)

  • 21. Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
    Schierova D; Roubalova R; Kolar M; Stehlikova Z; Rob F; Jackova Z; Coufal S; Thon T; Mihula M; Modrak M; Kverka M; Bajer L; Kostovcikova K; Drastich P; Hercogova J; Novakova M; Vasatko M; Lukas M; Tlaskalova-Hogenova H; Jiraskova Zakostelska Z
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease.
    Papa E; Docktor M; Smillie C; Weber S; Preheim SP; Gevers D; Giannoukos G; Ciulla D; Tabbaa D; Ingram J; Schauer DB; Ward DV; Korzenik JR; Xavier RJ; Bousvaros A; Alm EJ
    PLoS One; 2012; 7(6):e39242. PubMed ID: 22768065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers.
    Said HS; Suda W; Nakagome S; Chinen H; Oshima K; Kim S; Kimura R; Iraha A; Ishida H; Fujita J; Mano S; Morita H; Dohi T; Oota H; Hattori M
    DNA Res; 2014 Feb; 21(1):15-25. PubMed ID: 24013298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases.
    Ghavami SB; Rostami E; Sephay AA; Shahrokh S; Balaii H; Aghdaei HA; Zali MR
    Microb Pathog; 2018 Apr; 117():285-289. PubMed ID: 29477743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar Gut Bacterial Composition Between Patients With Ulcerative Colitis and Healthy Controls in a High Incidence Population: A Cross-sectional Study of the Faroe Islands IBD Cohort.
    Berbisá MÁF; Nielsen KR; Ingham AC; Midjord J; Hammer T; Patursson P; Vest NMO; Gregersen NO; Burisch J; Vang A
    Inflamm Bowel Dis; 2022 Jul; 28(7):1081-1089. PubMed ID: 35138361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease.
    Maukonen J; Kolho KL; Paasela M; Honkanen J; Klemetti P; Vaarala O; Saarela M
    J Crohns Colitis; 2015 Dec; 9(12):1088-95. PubMed ID: 26351391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut microbiota heterogeneity and assembly changes associated with the IBD.
    Sun Y; Li L; Xia Y; Li W; Wang K; Wang L; Miao Y; Ma S
    Sci Rep; 2019 Jan; 9(1):440. PubMed ID: 30679676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
    Cook L; Wong MQ; Rees WD; Schick A; Lisko DJ; Lunken GR; Wang X; Peters H; Oliveira L; Lau T; Mah R; Bressler B; Levings MK; Steiner TS
    Inflamm Bowel Dis; 2024 May; 30(5):820-828. PubMed ID: 37874904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
    Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease.
    Fernandes MA; Verstraete SG; Phan TG; Deng X; Stekol E; LaMere B; Lynch SV; Heyman MB; Delwart E
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):30-36. PubMed ID: 30169455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
    Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
    Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population.
    Kim HS; Oh SJ; Kim BK; Kim JE; Kim BH; Park YK; Yang BG; Lee JY; Bae JW; Lee CK
    Sci Rep; 2024 Oct; 14(1):23701. PubMed ID: 39390011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabarcoding of colonic cleansing fluid reveals unique bacterial members of mucosal microbiota associated with Inflammatory Bowel Disease.
    Banzragch M; Sanli K; Stensvold CR; Kurt O; Ari S
    Scand J Gastroenterol; 2023; 58(11):1253-1263. PubMed ID: 37337895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease.
    Tronstad RR; Kummen M; Holm K; von Volkmann HL; Anmarkrud JA; Høivik ML; Moum B; Gilja OH; Hausken T; Baines J; Karlsen TH; Fiskerstrand T; Hov JR
    Inflamm Bowel Dis; 2017 Oct; 23(10):1752-1761. PubMed ID: 28902124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
    Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
    Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.